Cargando…
Clinical significance of tumor necrosis and viability in non-small cell lung cancer
BACKGROUND: We included tumor necrosis (TN) and tumor viability (TV) in our prognostic assessment of patients with non-small cell lung cancer (NSCLC) and investigated their clinical significance. METHODS: Medical records of all consecutive subjects who underwent a lobectomy with standard mediastinal...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096282/ https://www.ncbi.nlm.nih.gov/pubmed/35572900 http://dx.doi.org/10.21037/jtd-21-1597 |
_version_ | 1784705940784676864 |
---|---|
author | Moon, Seok Whan Kim, Jae Jun Jeong, Seong Cheol Kim, Yong Hwan Han, Jung Wook |
author_facet | Moon, Seok Whan Kim, Jae Jun Jeong, Seong Cheol Kim, Yong Hwan Han, Jung Wook |
author_sort | Moon, Seok Whan |
collection | PubMed |
description | BACKGROUND: We included tumor necrosis (TN) and tumor viability (TV) in our prognostic assessment of patients with non-small cell lung cancer (NSCLC) and investigated their clinical significance. METHODS: Medical records of all consecutive subjects who underwent a lobectomy with standard mediastinal lymph node dissection for NSCLC between 2015 to 2016, were reviewed retrospectively. We analyzed the associations of TN and TV with various parameters associated with prognosis as well as survival in NSCLC patients. All analyses were performed regarding neoadjuvant therapy status [the group without neoadjuvant therapy (WON) vs. the group with neoadjuvant therapy (WN)]. RESULTS: A consecutive 154 patients (mean age: 65.0±10.1 years) were included into the present study. Fifteen patients underwent neoadjuvant therapy. Final pathologic stages were IA1 (n=13), IA2 (n=30), IA3 (n=32), IB (n=40), IIA (n=9), IIB (n=18), and IIIA (n=12). WN significantly showed higher TN (P=0.005) and lower TV (P<0.001) than WON. Tumors with vascular, lymphatic, and perineural invasion showed significantly lower TV and higher TN than cases without these features (P=0.014, P=0.019, and P=0.012 for TV; P=0.001, P<0.001, and P<0.001 for TN, respectively). Tumors with poorer differentiation had lower TV (P<0.001) and higher TN (P<0.001) than more differentiated tumors. There was a positive correlation between TN and tumor size (P<0.001) and a negative correlation between TV and tumor size (P=0.031). TN significantly increased as pathologic stage increased (P=0.001), and TV significantly decreased as pathologic stage increased (P=0.038). The group without TN survived significantly longer than the group with TN (P=0.016) in N0 disease and presence of TN and pT stage were independent prognostic factors for survival in N0 disease (P=0.037 and P=0.021, respectively). There was a positive correlation between TN and Ki-67 level (P=0.027). In WN, TN was significantly associated with differentiation (P=0.035), tumor size (P=0.008), and pT stage (P=0.031) but not overall pathologic stage or survival. CONCLUSIONS: Presence of histological TN was associated with prognosis of NSCLC, especially in N0 disease, and its usage as a diagnostic or prognostic tool and determination of resection extent could potentially provide prognostic information that can facilitate better management of NSCLC. |
format | Online Article Text |
id | pubmed-9096282 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-90962822022-05-13 Clinical significance of tumor necrosis and viability in non-small cell lung cancer Moon, Seok Whan Kim, Jae Jun Jeong, Seong Cheol Kim, Yong Hwan Han, Jung Wook J Thorac Dis Original Article BACKGROUND: We included tumor necrosis (TN) and tumor viability (TV) in our prognostic assessment of patients with non-small cell lung cancer (NSCLC) and investigated their clinical significance. METHODS: Medical records of all consecutive subjects who underwent a lobectomy with standard mediastinal lymph node dissection for NSCLC between 2015 to 2016, were reviewed retrospectively. We analyzed the associations of TN and TV with various parameters associated with prognosis as well as survival in NSCLC patients. All analyses were performed regarding neoadjuvant therapy status [the group without neoadjuvant therapy (WON) vs. the group with neoadjuvant therapy (WN)]. RESULTS: A consecutive 154 patients (mean age: 65.0±10.1 years) were included into the present study. Fifteen patients underwent neoadjuvant therapy. Final pathologic stages were IA1 (n=13), IA2 (n=30), IA3 (n=32), IB (n=40), IIA (n=9), IIB (n=18), and IIIA (n=12). WN significantly showed higher TN (P=0.005) and lower TV (P<0.001) than WON. Tumors with vascular, lymphatic, and perineural invasion showed significantly lower TV and higher TN than cases without these features (P=0.014, P=0.019, and P=0.012 for TV; P=0.001, P<0.001, and P<0.001 for TN, respectively). Tumors with poorer differentiation had lower TV (P<0.001) and higher TN (P<0.001) than more differentiated tumors. There was a positive correlation between TN and tumor size (P<0.001) and a negative correlation between TV and tumor size (P=0.031). TN significantly increased as pathologic stage increased (P=0.001), and TV significantly decreased as pathologic stage increased (P=0.038). The group without TN survived significantly longer than the group with TN (P=0.016) in N0 disease and presence of TN and pT stage were independent prognostic factors for survival in N0 disease (P=0.037 and P=0.021, respectively). There was a positive correlation between TN and Ki-67 level (P=0.027). In WN, TN was significantly associated with differentiation (P=0.035), tumor size (P=0.008), and pT stage (P=0.031) but not overall pathologic stage or survival. CONCLUSIONS: Presence of histological TN was associated with prognosis of NSCLC, especially in N0 disease, and its usage as a diagnostic or prognostic tool and determination of resection extent could potentially provide prognostic information that can facilitate better management of NSCLC. AME Publishing Company 2022-04 /pmc/articles/PMC9096282/ /pubmed/35572900 http://dx.doi.org/10.21037/jtd-21-1597 Text en 2022 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Moon, Seok Whan Kim, Jae Jun Jeong, Seong Cheol Kim, Yong Hwan Han, Jung Wook Clinical significance of tumor necrosis and viability in non-small cell lung cancer |
title | Clinical significance of tumor necrosis and viability in non-small cell lung cancer |
title_full | Clinical significance of tumor necrosis and viability in non-small cell lung cancer |
title_fullStr | Clinical significance of tumor necrosis and viability in non-small cell lung cancer |
title_full_unstemmed | Clinical significance of tumor necrosis and viability in non-small cell lung cancer |
title_short | Clinical significance of tumor necrosis and viability in non-small cell lung cancer |
title_sort | clinical significance of tumor necrosis and viability in non-small cell lung cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096282/ https://www.ncbi.nlm.nih.gov/pubmed/35572900 http://dx.doi.org/10.21037/jtd-21-1597 |
work_keys_str_mv | AT moonseokwhan clinicalsignificanceoftumornecrosisandviabilityinnonsmallcelllungcancer AT kimjaejun clinicalsignificanceoftumornecrosisandviabilityinnonsmallcelllungcancer AT jeongseongcheol clinicalsignificanceoftumornecrosisandviabilityinnonsmallcelllungcancer AT kimyonghwan clinicalsignificanceoftumornecrosisandviabilityinnonsmallcelllungcancer AT hanjungwook clinicalsignificanceoftumornecrosisandviabilityinnonsmallcelllungcancer |